Inflexion to acquire Sunovion Pharmaceuticals Europe

  • by


Inflexion is to acquire Sunovion Pharmaceuticals Europe (SPE) from US-based Sunovion Pharmaceuticals, according to a statement from parent company Sumitomo Dainippon Pharma.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *